Advertisement
JP Stocks

Nankai Chemical (4040.T) Surges 22.7% on Earnings Beat, Hits ¥3,790

May 16, 2026
5 min read

Key Points

Nankai Chemical 4040.T stock surges 22.7% to ¥3,790 on earnings beat.

PE ratio 7.65 offers attractive valuation versus sector average 17.64.

Strong fundamentals: ROE 28.9%, debt-to-equity 0.38, interest coverage 19.3x.

Meyka AI rates B+ with buy recommendation; five-year target ¥4,120.

Be the first to rate this article

Nankai Chemical Company,Limited (4040.T) delivered a powerful rally on May 15, 2026, with 4040.T stock surging 22.7% to close at ¥3,790 on the JPX. The Osaka-based chemicals manufacturer posted earnings that beat expectations, triggering strong buying interest across the sector. Trading volume jumped to 84,400 shares, more than seven times the daily average, signaling robust investor confidence. The stock now trades well above its 50-day average of ¥3,203 and 200-day average of ¥3,081, reflecting sustained momentum in the Basic Materials sector.

Advertisement

Earnings Catalyst Drives 4040.T Stock Higher

Nankai Chemical announced results on May 15, 2026, triggering the sharp rally in 4040.T stock. The company reported earnings per share (EPS) of ¥495.64, delivering solid profitability despite a challenging macro environment. Revenue grew 4.6% year-over-year, while gross profit margins held steady at 26.8%, demonstrating pricing power in inorganic chemicals and water treatment segments.

The earnings beat reflects strong demand for the company’s core products: industrial chemicals, water treatment disinfectants, and specialty chemicals. Net income per share of ¥1,291 underscores the company’s ability to convert revenue into shareholder value. With a PE ratio of just 7.65, 4040.T stock remains attractively valued compared to sector peers, offering investors exposure to a diversified chemicals portfolio with minimal valuation premium.

Valuation and Financial Strength Support 4040.T Stock

4040.T stock trades at a compelling discount to intrinsic value. The price-to-book ratio of 0.72 indicates the stock trades below tangible asset value, while the price-to-sales ratio of 0.37 reflects efficient revenue generation. Market capitalization stands at ¥7.69 billion, with 2.03 million shares outstanding.

Financial health remains robust. The current ratio of 1.70 ensures adequate liquidity for operations and dividends. Debt-to-equity of 0.38 signals conservative leverage, while interest coverage of 19.3x demonstrates strong ability to service obligations. Return on equity of 28.9% and return on assets of 12.6% rank among the strongest in the chemicals sector. Meyka AI rates 4040.T with a grade of B+, suggesting a buy rating based on sector comparison, financial growth, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Technical Setup and Price Momentum in 4040.T

The technical picture for 4040.T stock shows strong bullish momentum. The relative strength index (RSI) stands at 77.3, indicating overbought conditions but reflecting genuine buying pressure. The stock trades above both key moving averages, with the 50-day at ¥3,203 and 200-day at ¥3,081 providing support.

Volume analysis confirms conviction behind the move. Daily volume of 84,400 shares dwarfs the 11,175-share average, suggesting institutional participation. The stock reached an intraday high of ¥3,790, matching the closing price, while the day low of ¥3,575 held above the 50-day average. Year-to-date performance of 18.1% and six-month gain of 23.3% demonstrate consistent outperformance. Track 4040.T on Meyka for real-time updates on price action and technical levels.

Nankai Chemical Company,Limited Price Forecast

Meyka AI’s forecast model projects 4040.T stock reaching ¥3,792 over three years and ¥4,120 over five years, implying 9.0% and 8.7% upside respectively from current levels. The yearly forecast of ¥3,459 suggests near-term consolidation before the longer-term rally materializes. These projections factor in sector growth, company fundamentals, and historical volatility patterns.

The forecast assumes continued demand for specialty chemicals and water treatment solutions in Japan and export markets. Dividend yield of 1.58% provides income support, while the payout ratio remains conservative at 0%, allowing reinvestment in growth. Risks include commodity price swings, industrial production slowdowns, and currency fluctuations affecting export competitiveness. Investors should monitor quarterly earnings and sector trends for confirmation of the uptrend.

Advertisement

Final Thoughts

Nankai Chemical (4040.T) delivered a compelling earnings surprise on May 15, 2026, with 4040.T stock jumping 22.7% to ¥3,790 on strong fundamentals and attractive valuation. The company’s 7.65 PE ratio, robust profitability metrics, and conservative balance sheet position it well for sustained growth in the chemicals sector. With Meyka AI’s B+ grade and multi-year price targets suggesting further upside, 4040.T stock offers value-oriented investors exposure to a diversified chemicals manufacturer with proven execution and dividend support. Monitor quarterly results and sector dynamics for confirmation of the bullish thesis.

FAQs

Why did 4040.T stock surge 22.7% on May 15, 2026?

Nankai Chemical reported earnings exceeding expectations with ¥495.64 EPS and 4.6% revenue growth. Strong profitability and margins triggered institutional buying, increasing volume to 7.5x average.

What is the current PE ratio for 4040.T stock?

The PE ratio is 7.65, well below the sector average of 17.64, indicating attractive valuation. Price-to-book of 0.72 and price-to-sales of 0.37 confirm undervaluation.

What is Meyka AI’s rating for 4040.T stock?

Meyka AI rates 4040.T as B+ with a buy recommendation, considering sector performance, financial growth, key metrics, and analyst consensus. Ratings are not guaranteed.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)